Laetitia leads our efforts on vaccines policy and advocacy to encourage pharmaceutical innovation and improve people’s health and well-being around the world.

She oversees the Vaccines Committee, the interface between IFPMA members and international public health organizations involved in global immunization, which promotes sustainable policies and initiatives to support vaccine innovation and access to vaccines globally.

Prior to joining IFPMA, Laetitia worked as a clinical research associate for the multidisciplinary center on oncology at the University Hospital Lausanne.

She has a PhD in Molecular Biology from the University of Lausanne, Switzerland.

The COVID-19 pandemic has shown that, when we work together, we can achieve more than we ever thought possible. Together, we can give vaccines the greatest chance to make an even greater impact on our health, our communities, and our world.